Manuel Yepes Selected Research

Manuel Yepes Research Topics

Disease

15	Ischemic Stroke 12/2018 - 03/2004
14	Brain Ischemia (Cerebral Ischemia) 01/2019 - 11/2003
11	Stroke (Strokes) 03/2020 - 08/2002
9	Ischemia 01/2013 - 08/2002
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2013 - 02/2005
7	Hypoxia (Hypoxemia) 01/2018 - 10/2009
5	Seizures (Absence Seizure) 12/2004 - 06/2002
3	Dementia (Dementias) 10/2021 - 06/2002
3	Brain Edema (Cerebral Edema) 12/2009 - 08/2002
2	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 01/2020
2	Inflammation (Inflammations) 04/2021 - 01/2017
2	Multiple Sclerosis 06/2007 - 05/2007
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Insulin Resistance 03/2020
1	Cerebral Hemorrhage 10/2017
1	Necrosis 01/2017
1	Atherosclerosis 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2012
1	Parkinson Disease (Parkinson's Disease) 02/2010
1	Infarction (Infarctions) 02/2010
1	Edema (Dropsy) 12/2009
1	Neoplasms (Cancer) 10/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2009
1	Acidosis 03/2008
1	Central Nervous System Diseases (CNS Diseases) 05/2007
1	Brain Injuries (Brain Injury) 02/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2005
1	Pneumonia (Pneumonitis) 07/2004
1	Familial encephalopathy with neuroserpin inclusion bodies 03/2004
1	Ankylosis 07/2003
1	Embolic Stroke 08/2002
1	Neurologic Manifestations (Neurological Manifestations) 06/2002

Drug/Important Bio-Agent (IBA)

14	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2018 - 08/2002
9	PlasminogenIBA 10/2021 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 12/2015 - 06/2002
6	CytokinesIBA 02/2018 - 02/2005
5	Fibrinolysin FDA Link 01/2022 - 05/2009
5	NeuroserpinIBA 11/2010 - 06/2002
3	Serine Proteases (Serine Protease)IBA 01/2018 - 05/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 07/2012
2	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 04/2021 - 03/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 04/2021 - 12/2018
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 02/2018 - 01/2017
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 10/2014
2	platelet-derived growth factor C (PDGF-C)IBA 10/2017 - 07/2008
2	Oxygen (Dioxygen)IBA 01/2012 - 10/2009
2	Neuroprotective AgentsIBA 01/2012 - 10/2007
2	Kainic Acid (Kainate)IBA 02/2010 - 06/2002
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2009 - 01/2009
2	Cytokine TWEAKIBA 03/2007 - 02/2005
1	Enzyme Precursors (Zymogens)IBA 04/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018
1	Evans Blue (Blue, Evans)FDA Link 02/2018
1	Matrix Metalloproteinases (MMPs)IBA 02/2018
1	Coloring Agents (Dyes)IBA 02/2018
1	ezrinIBA 01/2018
1	Platelet-Derived Growth FactorIBA 10/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Factor XII (Hageman Factor)IBA 01/2017
1	ApolipoproteinsIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	SpectrinIBA 12/2015
1	NeurotoxinsIBA 01/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2012
1	Glutamic Acid (Glutamate)FDA Link 06/2011
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2010
1	6,7-dihydroxyflavoneIBA 02/2010
1	Claudin-5IBA 12/2009
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2009
1	Transcription Factors (Transcription Factor)IBA 10/2009
1	Cyclin D1IBA 09/2009
1	Proteinase-Activated ReceptorsIBA 05/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2008
1	Caspase 3 (Caspase-3)IBA 05/2008
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2008
1	NF-kappa B (NF-kB)IBA 10/2007
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2007
1	LDL Receptors (LDL Receptor)IBA 10/2007
1	AntibodiesIBA 06/2007
1	LigandsIBA 05/2007
1	Immunoglobulin G (IgG)IBA 04/2007
1	Cathepsin GIBA 07/2004
1	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2004
1	Plasminogen Activator Inhibitor 1IBA 07/2004
1	EnzymesIBA 07/2004
1	Gadolinium DTPA (Magnevist)FDA Link 08/2002

Therapy/Procedure

3	Intravenous Administration 11/2018 - 11/2013
2	Thrombectomy 12/2018 - 01/2017
2	Therapeutics 01/2015 - 10/2009
1	Thrombolytic Therapy 10/2017
1	Intraventricular Injections 07/2008